Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-18 · accession 0001765581-23-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-18 | JAZZ | GALA RENEE D | EVP, CFO | S - Sale | $131.75 | -6,000 | 36.0K | -14% | -$790.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-05-18 | S | D | 6,000 | $131.75 | 35,978 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.69 to $131.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |